Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cytek Biosciences (CTKB) Return on Sales (2020 - 2025)

Cytek Biosciences' Return on Sales history spans 6 years, with the latest figure at 0.71% for Q4 2025.

  • For Q4 2025, Return on Sales fell 88.0% year-over-year to 0.71%; the TTM value through Dec 2025 reached 0.33%, down 30.0%, while the annual FY2025 figure was 0.33%, 30.0% down from the prior year.
  • Return on Sales reached 0.71% in Q4 2025 per CTKB's latest filing, down from 0.1% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.17% in Q4 2024 to a low of 0.71% in Q4 2025.
  • Average Return on Sales over 5 years is 0.08%, with a median of 0.04% recorded in 2022.
  • Peak YoY movement for Return on Sales: increased 15bps in 2024, then tumbled -88bps in 2025.
  • A 5-year view of Return on Sales shows it stood at 0.01% in 2021, then skyrocketed by 474bps to 0.08% in 2022, then rose by 23bps to 0.09% in 2023, then soared by 77bps to 0.17% in 2024, then crashed by -525bps to 0.71% in 2025.
  • Per Business Quant, the three most recent readings for CTKB's Return on Sales are 0.71% (Q4 2025), 0.1% (Q3 2025), and 0.12% (Q2 2025).